Medscape Oncology

💊 Optimizing R/R DLBCL treatment requires evidence-based decisions! Explore bispecific antibody trial findings, treatment sequencing, and practical strategies for community-based care. 🎯 Enhance your expertise! mdsc.pe/4ex4Q3I #ASH26

🎯 Optimizing HER2-positive GEA care starts with informed decisions! Discover emerging anti-HER2 evidence, treatment sequencing strategies & practical approaches to managing adverse events. 💡 Learn more! mdsc.pe/4kmAm8o

🦟 Stay current on dengue prevention! Explore the latest data, strengthen vaccine 💉recommendations, and gain confidence addressing patient questions and concerns about dengue vaccination. 🌎 Click here now: mdsc.pe/4ARfGLF

🔄 Sequence matters in HER2-positive GEA. Dive into emerging anti-HER2 evidence, navigate treatment decisions across the patient journey & strengthen strategies for managing diarrhea and optimizing safety. 🤝 Advance your GEA approach—save your spot! mdsc.pe/4hk4FcR

Starting in 1 HOUR ➡️ mdsc.pe/4jYMo7M Master new strategies for refractory HSV! Join Dr. Kumar, Dr. Wald & Dr. McGee LIVE to optimize care for your patients. 🗓️ Today ⏰ 12:00pm ET #InfectiousDisease #HSV #CME #MedEd

🧬 MASH care is moving beyond liver-only thinking. Explore the MASLD-to-MASH spectrum, cardiometabolic risk, emerging therapies, noninvasive risk assessment, and phenotype-driven treatment strategies. 📊 Advance your approach—register today! mdsc.pe/3U4CNS7

LIVE TOMORROW ➡️ mdsc.pe/4jYMo7M Equip your practice with actionable insights on refractory HSV, toxicity management, & new treatments! Earn 0.25 CME credit. 🗓️ Oct 28th ⏰ 12:00pm ET #InfectiousDisease #CME #MedEd

🎯 From selecting the next therapy to managing toxicity, every decision counts. Review the latest anti-HER2 data in GEA, refine treatment sequencing & strengthen interprofessional strategies for managing diarrhea and patient safety. 🩺 Elevate your care—join us!mdsc.pe/4hk4FcR

🧪 Advancing care for systemic mastocytosis starts with the latest evidence happening at #ASH26! Explore clinical trial findings, assess disease control, and enhance interprofessional treatment decisions. 🚀 Stay informed—join this educational activity! mdsc.pe/4yfvJ3h

🔍 MDS treatment decisions are becoming increasingly precise. Discover how cytogenetic and molecular characteristics can guide care, examine trial data 🧪 across the disease continuum & strengthen team-based management of treatment complexities. ⚡ Turn evolving evidence into action—join us! mdsc.pe/4r4FVcQ #ASH26

🔬 How can you optimize care for patients with newly diagnosed multiple myeloma ? Explore clinical evidence for transplant-eligible and ineligible patients, personalized treatment strategies, and the importance of collaborative care. 💡 Strengthen your clinical decision-making—join this educational activity! mdsc.pe/3U0ktts #ASH26

🗣️ Better labs matter. So do better days. Discover how to navigate the move from first- to second-line PBC therapy, address symptoms and 🌿 biochemical parameters, and develop patient-centric management strategies. 🔬 Put the whole patient at the heart of PBC care—register today! mdsc.pe/4iRKdl

🧬 In MDS, the molecular details matter. Explore cytogenetic and molecular features that inform clinical decisions, review evolving 🔬 trial data & translate the evidence into treatment choices across the disease continuum. 🩸 Sharpen your MDS strategy! mdsc.pe/4r4FVcQ #ASH26

🔍 Could PFIC or ALGS be hiding in your adult patients? Strengthen recognition & diagnosis, navigate the appropriate use of targeted therapies 🧬 & discover how interprofessional care can address their multisystem impact. 🤝 Be ready for these cases— mdsc.pe/4h8ewDH

🎯 Optimizing prostate cancer care starts with informed treatment decisions! Explore ARPI trial data, identify candidates for mHSPC and nmCRPC therapies, and learn when to intensify treatment. 📈 Strengthen your knowledge—learn more! mdsc.pe/4hLfKoS #ESMO

🔄 Sequence matters in HER2-positive GEA. Dive into emerging anti-HER2 evidence, navigate treatment decisions across the patient journey & strengthen strategies for managing diarrhea and optimizing safety. 🤝 Advance your GEA approach—save your spot! mdsc.pe/4hk4FcR

🧪 Systemic mastocytosis care is evolving across the disease spectrum. Explore recent clinical trial data, identify patients who may benefit from advanced treatment & ✨ evaluate whether disease control is truly adequate. 🧭 Stay ahead of SM care—register today! mdsc.pe/4yhO28u #ASH26

🔬 How are emerging therapies shaping the future of platinum-resistant ovarian cancer (PROC) care? Join @BanerjeeSusana to examine the latest ADC evidence, treatment safety, and biomarker-driven decisions. 💡 Explore the latest insights—learn more! mdsc.pe/4dRs3xo #ESMO2026 #ESMO

🪁 There’s more to hemophilia care than bleed counts. Explore clinically meaningful differences between therapies and learn how to match treatment to each patient’s disease, priorities, and needs. 🧭 Strengthen shared decisions across the care team. Join us! mdsc.pe/4irU5mb #ASH26

💊 Optimizing R/R DLBCL treatment requires evidence-based decisions! Explore bispecific antibody trial findings, treatment sequencing, and practical strategies for community-based care. 🎯 Enhance your expertise! mdsc.pe/4ex4Q3I #ASH26